Aurora Cannabis sees record Q4-2025 revenues driven by international sales, but low profits and weak 2026 outlook keep stock ...

Q4 2025 Earnings Call Transcript June 18, 2025 Aurora Cannabis Inc. misses on earnings expectations. Reported EPS is $0.07 ...

A top Canadian global medical cannabis company has issued a firm denial of recent misinformation circulating online regarding ...

Aurora Cannabis Inc. says a pair of AI‑generated articles that surfaced online this week—one alleging a $215 million takeover ...

Aurora's CEO defends partnership with PMI-owned Aspeya, saying it's about science, not Big Tobacco. Here's what we learned.

This was the stock's second consecutive day of losses.

Aurora CEO says medical cannabis is profitable and growing—even if investors aren't seeing it yet. Here's what's driving the ...

Aurora Cannabis faces headwinds as Q4/FY2025 revenues grow but profitability declines due to one-time expenses. Check out why ...

Aurora Cannabis shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its ...

Aurora Cannabis Inc. closed 18.33% short of its 52-week high of $7.20, which the company reached on August 15th.

Solon is considering zoning changes that would limit how close together marijuana dispensaries and vape shops can operate to ...

The global cannabis cultivation industry is projected to grow from $180.7 billion in 2025 to $651.8 billion by 2034, ...